Research News
View articles by month and year
11–20 of 31 articles
-
Arimidex Still Better Than Tamoxifen After Surgery to Reduce Recurrence Risk
After 10 years of follow-up, research shows that 5 years of Arimidex is better at reducing the risk of hormone-receptor-positive breast cancer recurrence than 5 years of tamoxifen.
-
Aromatase Inhibitor Before Surgery May Make Lumpectomy an Option
Many women diagnosed with hormone-receptor-positive, early-stage breast cancer for whom mastectomy was recommended may be candidates for lumpectomy after taking an aromatase inhibitor.
-
New Guidelines Prefer Aromatase Inhibitors Over Tamoxifen
The American Society of Clinical Oncology has issued new guidelines on taking hormonal therapy medicines after breast cancer surgery.
-
High-Dose Vitamin D May Ease Joint Pain from Arimidex
A small study suggests that very high doses of vitamin D taken each week may help ease muscle and joint pain associated with Arimidex.
-
Higher Faslodex Dose More Effective Against Metastatic Breast Cancer
Advanced-stage, hormone-receptor-positive breast cancers treated with 500 mg of Faslodex (double the usual dose) had a slightly better response than cancers treated with 250 mg of Faslodex (the usual dose).
-
Estradiol Therapy May Help Some Advanced-Stage Breast Cancers Start Responding to Hormonal Therapy Again
A small study found that estradiol, a form of estrogen, was an effective treatment for about 30% of advanced-stage, hormone-receptor-positive breast cancers that had stopped responding to hormonal therapy.
-
Aromatase Inhibitors Slightly Better Than Tamoxifen for Postmenopausal Women
A review of a number of studies confirms that aromatase inhibitors reduce the risk of early-stage, hormone-receptor-positive breast cancer coming back better than tamoxifen in post-menopausal women.
-
Estradiol May Make Breast Cancer Start Responding to Aromatase Inhibitors Again
A small study found that estradiol, a form of estrogen, can make advanced-stage, hormone-receptor-positive breast cancers that have stopped responding to hormonal therapy start responding again in some cases.
-
Hormonal Therapy Side Effects Linked to Lower Risk of Recurrence
New research suggests a link between hormonal therapy side effects (hot flashes, night sweats, joint pain) and a reduced risk of breast cancer coming back.
-
Arimidex Doesn’t Seem to Cause Thinking or Memory Problems
A small study shows that women who took the aromatase inhibitor Arimidex (chemical name: anastrozole) for 2 years didn't have any more thinking and memory problems than women who took a placebo pill for 2 years.
11–20 of 31 articles
